BioAffinity Technologies, Inc. 2024 Financial Report: Stock Insights & Market Overview

$BIAF
Form 8-K
Filed on: 2024-12-20
Source
BioAffinity Technologies, Inc. 2024 Financial Report: Stock Insights & Market Overview

Based on the provided XML section from a financial report, here are the key insights and important information extracted:

  1. Company Identification:
  • Company Name: BioAffinity Technologies, Inc.
  • CIK Number: 0001712762
  • SEC File Number: 001-41463
  • EIN: 46-5211056
  • Address: 3300 Nacogdoches Road, Suite 216, San Antonio, TX 78217
  • Contact Number: (210) 698-5334
  1. Reporting Date:
  • Filing Date: December 19, 2024
  • Period Covered: The report is for a single day on December 19, 2024.
  1. Stock Information:
  • Common Stock: The par value is stated as $0.007 per share.
  • Type of Stock: Common Stock is mentioned, which indicates the equity issued by the company.
  • Warrants: The document references "Tradeable Warrants to purchase Common Stock," suggesting the company has issued warrants that can be traded.
  1. Units of Measure:
  • All monetary values are reported in USD.
  • Shares are indicated as the unit of measure for stock-related transactions.
  1. Market Listing:
  • The common stock is listed on NASDAQ under the symbol "BIAF."
  • The warrants are also listed on NASDAQ under the symbol "BIAFW."
  1. Contextual Information:
  • The report uses XBRL (eXtensible Business Reporting Language), which is a format for electronic submission of financial reports to the SEC. This allows for structured and automated data analysis.

This report highlights the company's capital structure through its common stock and warrants, along with essential identifying information and the date of the filing. The par value of the stock and the trading status of the warrants are critical for investors assessing the company's equity offerings.